Frontiers in pharmacology
暂无分享,去创建一个
[1] T. O'donohue,et al. The opiomelanotropinergic neuronal and endocrine systems , 1982, Peptides.
[2] J. Marx. Cloning the acetylcholine receptor genes. , 1983, Science.
[3] P. Molinoff,et al. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. , 1983, The Journal of pharmacology and experimental therapeutics.
[4] R. Meganathan,et al. Biosynthesis of o-succinylbenzoic acid in a men- Escherichia coli mutant requires decarboxylation of L-glutamate at the C-1 position. , 1981, Biochemistry.
[5] J. Scott,et al. Rapid decrease in rat brain beta adrenergic receptor binding during combined antidepressant alpha-2 antagonist treatment. , 1983, The Journal of pharmacology and experimental therapeutics.
[6] J. Oates,et al. Increased production of prostaglandin D2 in patients with systemic mastocytosis. , 1980, The New England journal of medicine.
[7] M. Palkovits,et al. Distribution of vasoactive intestinal polypeptide (VIP) in the rat brain stem nuclei , 1982, Brain Research.
[8] G. Mannering,et al. Sequential administrations of polyriboinosinic acid and polyribocytidylic acid induce interferon and depress the hepatic cytochrome P-450-dependent monooxygenase system. , 1982, Biochemical and biophysical research communications.
[9] H. Bourne,et al. Fibroblast defect in pseudohypoparathyroidism, type I: reduced activity of receptor-cyclase coupling protein. , 1981, The Journal of clinical endocrinology and metabolism.